Aytu Biopharma (AYTU) Cash from Investing Activities Growth (1y) (2016 - 2025)
Aytu Biopharma (AYTU) Cash from Investing Activities Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 13.93% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 57.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -186.78% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 551.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 526.11% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -3,664.79% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -3.45% |
| 10 | Aytu Biopharma | 21.45 Mn | -5.27 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -111.72% |
| Jun 30, 2025 | -8,773.53% |
| Mar 31, 2025 | -53.33% |
| Dec 31, 2024 | 183.33% |
| Sep 30, 2024 | 601.32% |
| Jun 30, 2024 | 78.06% |
| Mar 31, 2024 | -4,600.00% |
| Dec 31, 2023 | -3,380.00% |
| Sep 30, 2023 | -280.95% |
| Jun 30, 2023 | -278.05% |
| Mar 31, 2023 | 101.43% |
| Dec 31, 2022 | 99.84% |
| Sep 30, 2022 | 148.84% |
| Jun 30, 2022 | 98.31% |
| Dec 31, 2021 | -10,070.00% |
| Sep 30, 2021 | -855.56% |
| Jun 30, 2021 | -5,259.19% |
| Dec 31, 2020 | 99.39% |
| Sep 30, 2020 | 99.14% |
| Jun 30, 2020 | 52.90% |